Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ARIAD Pharmaceuticals Inc (NASDAQ:ARIA)

7.85
Delayed Data
As of Jul 30
 +0.07 / +0.90%
Today’s Change
4.90
Today|||52-Week Range
9.89
+14.26%
Year-to-Date

Today’s Trading

Previous close7.78
Today’s open7.75
Day’s range7.57 - 7.88
Volume3,841,168
Average volume (3 months)3,276,285
Market cap$1.5B
Dividend yield--
Data as of 3:59pm ET, 07/30/2015

Growth & Valuation

Earnings growth (last year)+41.61%
Earnings growth (this year)-23.10%
Earnings growth (next 5 years)+41.39%
Revenue growth (last year)+131.36%
P/E ratioNM
Price/Sales12.18
Price/Book18.03

Competitors

 Today’s
change
Today’s
% change
FGENFibroGen Inc+0.34+1.51%
NKTRNektar Therapeutics+0.16+1.31%
EXELExelixis Inc-0.06-1.07%
DBVTDBV Technologies SA-0.51-1.17%
Data as of 3:59pm ET, 07/30/2015

Financials

Next reporting dateAugust 5, 2015
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$105.4M
Annual profit (last year)-$162.6M
Net profit margin-154.25%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Harvey J. Berger
Chief Financial Officer, Treasurer &
Executive VP
Edward M. Fitzgerald
Corporate headquarters
Cambridge, Massachusetts

Forecasts